Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Thursday, March 29, 2012 at 10:00AM PDT, to discuss fourth quarter and full year 2011 financial results and provide a business update.

Conference call details:

Date:	Thursday, March 29, 2012
Time:	1:00pm EDT, 10:00am PDT
Dial-in (U.S. and Canada):	(877) 681 – 1326
Dial-in (International):	(708) 290 – 1158
Web cast:	www.talontx.com

An archived version of the webcast will also be available via the company's website following the call.

About Talon Therapeutics

Talon Therapeutics, Inc. is a biopharmaceutical company dedicated to seizing upon medical opportunities, efficiently and expertly leading product candidates through clinical development, and transferring value to patients, patient care providers, shareholders, corporate partners, and employees.

In addition to Marqibo and Menadione Topical Lotion, the Company has additional pipeline opportunities some of which, like Marqibo, improve delivery and enhance the therapeutic benefits of well characterized, proven chemotherapies and enable high potency dosing without increased toxicity.

The Talon Therapeutics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3290

CONTACT: Talon Therapeutics, Inc.
         Investor & Media Contacts:
         Investor Relations Team
         (650) 588-6641
         investor.relations@talontx.com